• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Insider Selling by 22nd Century's VP of Research and Development

August 11, 2017

 (Photo Credit - Rob Hurson)


An insider at 22nd Century Group, Inc. (NYSE:XXII) submitted a Form 4 to the SEC for a recent sale of XXII shares, often considered to be a bearish signal for companies.


Related: 7 Key Takeaways from XXII's Q2 Earnings Release


Officers and directors of publicly traded companies have the most complete picture of what is going on inside of their organization. Therefore, their transactions in their own company's stock becomes a useful signal for traders and investors to track.


Insider Selling by VP of Research & Development


The Vice President of R&D for 22nd Century Group, Dr. Michael Moynihan, has filed a Statement of Changes in Beneficial Ownership (Form 4) with the SEC on August 2nd to report selling in XXII. On July 31st, Dr. Moynihan sold 29,532 shares of XXII at a price of $2.00 per share. As of the writing of this article, shares of XXII are trading slightly higher at $2.04 per share. Earlier this week, shares of XXII traded as high as $2.84 per share following an FDA announcement. 


The sale amounted to an divestment of $59,064. Following the transactions, Dr. Moynihan beneficially owns 917,220 more shares of XXII. While the stock sale was part of an automatic 10b-5(1) selling plan set up back in 2015, we believe that any and all insider transactions are worth watching.





To learn more about 22nd Century Group, Inc., be sure to check out the company's profile in our marijuana stocks databaseAlso, be sure to subscribe to one or more of our free newsletters so you never miss an important update. If you haven't already, connect with The Daily Marijuana Observer on Facebook, Twitter, and Instagram



Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.